Dr Karine Mardon current position at The National Imaging Facility consists of leading the preclinical molecular imaging research at The Centre for Advanced Imaging/UQ.

Dr Karine Mardon has established a network of collaborators in key areas of molecular imaging, providing NIF users with access to a “one stop shop” in a wide range of research areas involving PET and SPECT imaging. She has developed extensive collaborations with Australian researchers in various areas of molecular imaging, from the development and validation of new neuroimaging tracers for early diagnosis of neurodegenerative diseases, to oncology, with the development and validation of new tracers with theranostic applications.

 

Researcher biography

Dr Karine Mardon is the Facility Manager for the preclinical PET/CT for the Queensland Node of the National Imaging Facility (NIF) as part of the National Collaborative Research Infrastructure Scheme (NCRIS), based at the Centre for Advanced Imaging, The University of Queensland. Current research projects include:

  • Characterization of new Cannabinoid type 2 receptors as biomarkers for PET-imaging of neuroinflammation

  • Development of PET ligands for in vivo imaging of the endocannabinoid αβ-hydrolase domain 6 (ABHD6)

  • Development and characterization of novel radiotracers for PET imaging of Neuroinflammation

  • Development of novel brain specific PET ligands to study oxytocin receptors

  •  In vivo evaluation of PET and near-infrared tracers targeting oxytocin receptors in breast tumours

  • Evaluation of drugs developed for the study of movement disorders using PET and SPECT imaging